Literature DB >> 192295

Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase.

R Käser-Glanzmann, M Jakäbovä, J N George, E F Lüscher.   

Abstract

The events involved in platelet shape change, aggregation, the release reaction and contraction are thought to be mediated by the availability of Ca2+. Increased cytoplasmic calcium, released from intracellular stores, triggers platelet activity, and increased concentration of adenosine 3',5'-cyclic monophosphate (cyclic AMP) inhibits platelet alterations. We have studied the hypothesis that cyclic AMP may regulate the level of platelet cytoplasmic calcium by stimulating calcium removal by a membrane system. Such a hypothesis would be consistent with the reversibility of most manifestations of platelet activation. Human platelets were sonicated and unlysed platelets, mitochondria and granules were removed by centrifugation at 19 000 X g. Electron microscopy shows that the sediment, after centrifugation of the supernatant at 40 000 X g consists to a large extent of membrane vesicles. Such preparations actively concentrate calcium, as measured by the uptake of 45Ca, and also have the maximal calcium-stimulated ATPase activity. Optimal calcium uptake requires ATP and oxalate, and release of calcium from loaded vesicles was stimulated by the calcium ionophore A23187 and inhibited by LaCl3. These data indicate that calcium was being actively concentrated within membrane vesicles. After washing of such preparations in the absence of ATP, their capacity to take up Ca2+ is reduced to an initial value of 2.8 nmol/mg protein per min. In the presence of 2 - 10(6) M cyclic AMP to which was added a protein kinase preparation from human platelets, up to a 3-fold increase of this rate of uptake was observed. These results suggest that in platelets, as in muscle, cyclic AMP is a regulatory factor in the control of cytoplasmic calcium. Although the cyclic nucleotide may have still other functions, it appears likely that the well-known inhibition of many platelet activities by high intracellular cyclic AMP concentrations is directly linked to the stimulation of the removal of Ca2+ from the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192295     DOI: 10.1016/0005-2736(77)90336-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

1.  Subcellular distribution of the different platelet proteins phosphorylated on exposure of intact platelets to ionophore A23187 or to prostaglandin E1. Possible role of a membrane phosphopolypeptide in the regulation of calcium-ion transport.

Authors:  J E Fox; A K Say; R J Haslam
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

2.  Phosphodiesterase-inhibitors enoximone and piroximone in cardiac surgery: influence on platelet count and function.

Authors:  J Boldt; C Knothe; B Zickmann; C Herold; E Dapper; G Hempelmann
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets.

Authors:  S L Pfueller; D Logan; T T Tran; R A Bilston
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

4.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

5.  Correlated expression of the 97 kDa sarcoendoplasmic reticulum Ca(2+)-ATPase and Rap1B in platelets and various cell lines.

Authors:  C Magnier; R Bredoux; T Kovacs; R Quarck; B Papp; E Corvazier; J de Gunzburg; J Enouf
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.

Authors:  H Affolter; P Erne; E Bürgisser; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

7.  Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

Authors:  H A Cooper; K J Clemetson; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart.

Authors:  L M Villa; E Salas; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  The phosphoprotein that regulates platelet Ca2+ transport is located on the plasma membrane, controls membrane-associated Ca2(+)-ATPase and is not glycoprotein Ib beta-subunit.

Authors:  A Darnanville; R Bredoux; K J Clemetson; N Kieffer; N Bourdeau; S Levy-Toledano; J P Caen; J Enouf
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

10.  Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.

Authors:  J C Fantone; W A Marasco; L J Elgas; P A Ward
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.